Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Roche Holding AG (RO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
236.80 -2.40    -1.00%
11:31:00 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH0012032113 
VALOR:  1203211
  • Volume: 41,602
  • Bid/Ask: 236.60 / 237.00
  • Day's Range: 236.20 - 239.80
Roche Holding 236.80 -2.40 -1.00%

RO Recent Sentiments

 
This page contains information on users’ sentiments for the Roche Holding AG stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 24, 2024 Thomas Tsiavos   242.40 +2.31%
Apr 18, 2024 Luis Teran   237.00 Apr 22, 2024 @ 244.20 -3.04%
Apr 15, 2024 Philippe Szerer   241.80 -2.07%
Apr 11, 2024 Federico Bosi   244.40 Apr 15, 2024 @ 242.60 +0.74%
Apr 09, 2024 Zoltan Varga   232.80 Apr 15, 2024 @ 242.60 +4.21%
Apr 05, 2024 Francesco Ceci...   235.60 +0.51%
Apr 05, 2024   236.00 Apr 08, 2024 @ 232.80 +1.36%
Apr 03, 2024 SHIVENDU TRIPATHI   239.00 -0.92%
Mar 28, 2024 Jeannette Peck   240.80 Apr 01, 2024 @ 243.00 -0.91%
Mar 21, 2024 Fischer Urs   237.60 Apr 12, 2024 @ 241.80 +1.77%
Mar 20, 2024 pawel duda   241.60 Apr 12, 2024 @ 241.80 +0.08%
Mar 18, 2024 spoo ok   241.80 Mar 20, 2024 @ 243.20 -0.58%
Mar 14, 2024 Philippe Szerer   244.40 Apr 05, 2024 @ 231.60 -5.24%
Mar 14, 2024 Paolo Fazio   244.00 Apr 05, 2024 @ 231.60 -5.08%
Mar 14, 2024 Michelle Alessi   246.00 Apr 05, 2024 @ 231.60 -5.85%
Mar 14, 2024 Neal Walker   246.60 Mar 15, 2024 @ 242.60 +1.62%
Mar 13, 2024 Trevor Street   258.60 Mar 18, 2024 @ 242.00 -6.42%
Mar 08, 2024 Anita Vacca   251.80 Mar 11, 2024 @ 255.60 -1.51%
Mar 05, 2024 Gianbattista Giani   250.40 Mar 11, 2024 @ 255.60 -2.08%
Feb 29, 2024 Long Nguyễn   246.60 Mar 04, 2024 @ 246.40 -0.08%
Feb 26, 2024 CHÂU SANG TRẦN   246.40 Mar 04, 2024 @ 246.40 0.00%
Feb 19, 2024 Paolo Potenza   245.00 Mar 15, 2024 @ 242.60 -0.98%
Feb 13, 2024 Kerstin Reinhardt   243.20 Mar 08, 2024 @ 252.80 +3.95%
Feb 13, 2024 Max Weiler   242.80 Mar 08, 2024 @ 252.80 +4.12%
Feb 09, 2024 Patric Pecolat   238.20 Feb 12, 2024 @ 240.40 -0.92%
Feb 06, 2024 Raphaël Rosat   241.00 Mar 01, 2024 @ 246.80 +2.41%
Feb 05, 2024 Eduardo Gil...   244.60 Mar 01, 2024 @ 246.80 -0.90%
Feb 02, 2024 Dietmar Knoch   247.00 Feb 05, 2024 @ 244.00 +1.21%
Feb 01, 2024 Andrew Inglis   251.00 Feb 23, 2024 @ 247.80 -1.27%
Jan 27, 2024 DaknutA5519   263.60 Jan 29, 2024 @ 261.20 -0.91%
Jan 23, 2024 Alfredo Bosca   265.60 Jan 29, 2024 @ 261.20 -1.66%
Jan 16, 2024 JL Ragnarok   270.80 Jan 22, 2024 @ 265.60 -1.92%
Jan 15, 2024 Dorothy Van Wymersch   270.00 Feb 09, 2024 @ 238.60 +11.63%
Jan 12, 2024 Régis Para   272.20 Feb 02, 2024 @ 248.00 -8.89%
Dec 18, 2023 Wildhaber Beat   261.80 Dec 25, 2023 @ 260.00 -0.69%
Dec 18, 2023 clotilde perez   260.00 Dec 18, 2023 @ 261.60 +0.62%
Dec 07, 2023 Trevor Street   266.40 Dec 11, 2023 @ 271.60 +1.95%
Dec 04, 2023 Nuno Agapito   253.00 Dec 04, 2023 @ 261.20 -3.24%
Nov 30, 2023 xxx xxx   249.60 Dec 22, 2023 @ 260.00 +4.17%
Nov 28, 2023 Rasim Karimov   246.40 Dec 22, 2023 @ 260.00 +5.52%
Nov 22, 2023 Liviu Pletea   251.80 Nov 30, 2023 @ 249.20 -1.03%
Nov 14, 2023 Armando Gavezzoli   253.60 Dec 08, 2023 @ 272.00 +7.26%
Nov 07, 2023 Edwin Luethi   253.40 Nov 07, 2023 @ 253.40 0.00%
Nov 06, 2023 Thorben Mild   251.60 Dec 01, 2023 @ 253.00 +0.56%
Nov 02, 2023 Gui Del   254.00 Nov 08, 2023 @ 255.00 -0.39%
Oct 24, 2023 Rider Biglia   250.60 Nov 30, 2023 @ 249.20 -0.56%
Oct 20, 2023 Paolo Potenza   253.60 Nov 30, 2023 @ 249.20 -1.74%
Oct 20, 2023 chicca gekko   254.00 Nov 30, 2023 @ 249.20 -1.89%
Oct 19, 2023 Luis ReRo   253.20 Nov 30, 2023 @ 249.20 -1.58%
Oct 19, 2023 Elmar Stark   252.60 Nov 30, 2023 @ 249.20 +1.35%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RO Comments

Write your thoughts about Roche Holding AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Lee John
Lee John Nov 16, 2020 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
13.11.2020. CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza. This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
Jonny Tr
Jonny Tr May 04, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just like Biolidics. they get approval for Covid19 tests kits in USA
Billy Hanafi
Billy Hanafi Jan 25, 2019 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
edgard hajjar
edgard hajjar May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the historical price adjusted for stock splits?
Billy Hanafi
Billy Hanafi May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email